Captopril, a potent angiotensin-converting enzyme (ACE) inhibitor, has shown to be a significant therapeutic agent in the treatment of hypertension and other cardiovascular conditions. Its pharmacological involves preventing the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This results in vasodilation and a reduction in